fbpx
Size of letters 1x
Site color
Image
Additionally
Line height
Letter spacing
Font
Embedded items (videos, maps, etc.)
 

Pharma MeetUP: “Counterfeit Medicines in Ukraine. Anti-Counterfeiting Algorithm”

12/ 01/ 2022
  January 20, 2022, 10:00-12:30 Creative States Arsenal, meeting room, 8 Moskovska Street, Kyiv Format: hybrid (offline* + online). Participation: free of charge REGISTRATION The European Business Association (EBA) Health Care Committee and Legal Alliance Company are delighted to invite you to discuss the problem of counterfeit medicines and necessary prompt actions of pharmaceutical manufacturers in case of its detection. The guidelines entitled MEDICINES: ANTI-COUNTERFEITING IN UKRAINE / ACTION PLAN will be presented at the roundtable conference for the first time. The guidelines** developed by Legal Alliance Companys lawyers along with specialists from the Prosecutor Generals Office (PGO) of Ukraine on the results of the major case of counterfeit medicines in Ukraine and one of the major ones in the world. The publication provides concise and accessible operational guidelines to counteract the manufacturing of counterfeit medicines. Target audience include directors, managers and lawyers of pharmaceutical companies; professional and business associations; representatives of government agencies and media TOPICS UNDER DISCUSSION Problem of counterfeit medicines. Hot button issues of pharmaceutical manufacturers. Impediments in the investigation and control of illicit medicine trafficking. Findings of the pretrial investigation of several criminal proceedings on counterfeit medicines by PGO and their transfer to court. Case on counterfeit medicines in Ukraine on a global scale: Organization of anti-counterfeiting by the affected pharmaceutical companies. Experience of cooperation with the Pharmaceutical Security Institutes representatives. What to adopt for Ukraine? 4) Criteria for detecting counterfeit medicines and ways of disclosing the distribution channels for counterfeit products. 5) Action plan for pharmaceutical companies, if there is a suspicion of counterfeit pharmaceuticals. 6) Outcomes of the discussion. MODERATORS Dmytro Lurye, Manager, Healthcare Committee, EBA Illya Kostin, Partner, Legal Alliance Discussions participants: Oleksii Bezhevets, Partner, Legal Alliance Oleksii Boniuk, Head of the Department of Criminal Law Policy and Investment Protection, PGO Valerii Zymohliad, Prosecutor, PGO Volodymyr Redko, Executive Director, APRaD Representatives of pharmaceutical companies, the Ministry of Health of Ukraine, the State Service of Ukraine on Medicines and Drugs Control are invited to participate.   * The number of places in the room is limited. Presence in the room requires confirmation of vaccination/negative result of COVID-19 PCR test/document on the persons recovery from the disease (under Cabinet of Ministers of Ukraine Resolution No.1236 of December 9, 2020, as amended and the decision of the Commission on Environmental Safety, Manmade Disaster and Emergency Response of Kyiv City State Administration), protocol No.47). ** All participants of the roundtable conference will receive a copy of the guidelines.

January 20, 2022, 10:00-12:30

Creative States Arsenal, meeting room, 8 Moskovska Street, Kyiv

Format: hybrid (offline* + online). Participation: free of charge

REGISTRATION

The European Business Association (EBA) Health Care Committee and Legal Alliance Company are delighted to invite you to discuss the problem of counterfeit medicines and necessary prompt actions of pharmaceutical manufacturers in case of its detection.

The guidelines entitled “MEDICINES: ANTI-COUNTERFEITING IN UKRAINE / ACTION PLAN” will be presented at the roundtable conference for the first time. The guidelines** developed by Legal Alliance Company’s lawyers along with specialists from the Prosecutor General’s Office (PGO) of Ukraine on the results of the major case of counterfeit medicines in Ukraine and one of the major ones in the world. The publication provides concise and accessible operational guidelines to counteract the manufacturing of counterfeit medicines.

Target audience include directors, managers and lawyers of pharmaceutical companies; professional and business associations; representatives of government agencies and media

TOPICS UNDER DISCUSSION

  1. Problem of counterfeit medicines. “Hot button issues” of pharmaceutical manufacturers. Impediments in the investigation and control of illicit medicine trafficking.
  2. Findings of the pretrial investigation of several criminal proceedings on counterfeit medicines by PGO and their transfer to court.
  3. Case on counterfeit medicines in Ukraine on a global scale:
  • Organization of anti-counterfeiting by the affected pharmaceutical companies.
  • Experience of cooperation with the Pharmaceutical Security Institute’s representatives. What to adopt for Ukraine?

4) Criteria for detecting counterfeit medicines and ways of disclosing the distribution channels for counterfeit products.

5) Action plan for pharmaceutical companies, if there is a suspicion of counterfeit pharmaceuticals.

6) Outcomes of the discussion.

MODERATORS

  • Dmytro Lurye, Manager, Healthcare Committee, EBA
  • Illya Kostin, Partner, Legal Alliance
  • Discussion’s participants:
  • Oleksii Bezhevets, Partner, Legal Alliance
  • Oleksii Boniuk, Head of the Department of Criminal Law Policy and Investment Protection, PGO
  • Valerii Zymohliad, Prosecutor, PGO
  • Volodymyr Redko, Executive Director, APRaD

Representatives of pharmaceutical companies, the Ministry of Health of Ukraine, the State Service of Ukraine on Medicines and Drugs Control are invited to participate.

 

* The number of places in the room is limited. Presence in the room requires confirmation of vaccination/negative result of COVID-19 PCR test/document on the person’s recovery from the disease (under Cabinet of Ministers of Ukraine Resolution No.1236 of December 9, 2020, as amended and the decision of the Commission on Environmental Safety, Manmade Disaster and Emergency Response of Kyiv City State Administration), protocol No.47).

** All participants of the roundtable conference will receive a copy of the guidelines.

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.

Start
in the Telegram bot
Read articles. Share in social networks
0 Shares

Spelling error report

The following text will be sent to our editors: